Japanese Astellas Pharma has bought privately-owned biotech Quethera for $109 million, gaining access to its gene therapy focused on developing novel treatments for glaucoma and eye disorders. UK ...

Sharing Sensitive Stories Online:Qualitative Research with Interdisciplinary Arts & Abortion withSarah Webb, MFA, CPA ’22 The silence (and silencing) of untold abortion stories helped opponents ...

Linc Housing Breaks Ground on 100th Development 2 MIN READ ...